These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2464666)

  • 1. Effects of oxotremorine on neuronal RNA and chromatin in thalamic cholinoceptive sites.
    Martin LJ; Morse JD; Pritchard GA; Kim YH; Anthony A
    J Neurol Sci; 1988 Sep; 86(2-3):159-69. PubMed ID: 2464666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytophotometric analysis of neuronal chromatin and RNA changes in oxotremorine-treated rats.
    Martin LJ; Doebler JA; Anthony A
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):41-8. PubMed ID: 2418445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of HI-6 and pralidoxime on neuronal RNA in thalamic cholinergic sites.
    Martin LJ; Doebler JA; Anthony A
    J Neurol Sci; 1985 Nov; 71(1):1-8. PubMed ID: 2418157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytophotometric analysis of T-2 toxin induced alterations in chromatin condensation and neuronal nuclear volume of rat supraoptic-magnocellular neurons.
    Ballough GP; Pritchard GA; Miller-Patrick K; Kan RK; Anthony A
    Life Sci; 1989; 45(2):189-96. PubMed ID: 2473368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytophotometric analyses of thalamic neuronal RNA in soman intoxicated rats.
    Martin LJ; Doebler JA; Shih TM; Anthony A
    Life Sci; 1984 Oct; 35(15):1593-600. PubMed ID: 6207406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytophotometric analysis of magnocellular azure B-RNA and Feulgen-DNA following chronic GABA infusion into the nucleus basalis of rats.
    Ballough G; Majchrzak M; Strauss J; Kan R; Anthony A; Will B
    Life Sci; 1992; 50(18):1299-310. PubMed ID: 1373212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scanning cytophotometric analysis of brain neuronal nuclear chromatin changes in acute T-2 toxin-treated rats.
    Martin LJ; Doebler JA; Anthony A
    Toxicol Appl Pharmacol; 1986 Sep; 85(2):207-14. PubMed ID: 3764907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytophotometric assessment of T-2 toxin induced alterations in azure B-RNA and Coomassie-protein in supraoptic-magnocellular neurons of rat hypothalami.
    Ballough GP; Pritchard GA; Strauss JA; Lane MA; Malmrose LC; Song SJ; Packwood WH; Anthony A
    Life Sci; 1989; 45(24):2313-22. PubMed ID: 2481203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex.
    Lin Y; Phillis JW
    Eur J Pharmacol; 1991 Jul; 200(1):45-52. PubMed ID: 1722754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
    Harsing LG; Zigmond MJ
    Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography.
    Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
    Neuroscience; 1992; 47(2):367-93. PubMed ID: 1641129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels.
    Lechner SG; Mayer M; Boehm S
    J Physiol; 2003 Dec; 553(Pt 3):789-802. PubMed ID: 14555721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats.
    Wang JQ; McGinty JF
    Brain Res; 1997 Feb; 748(1-2):62-70. PubMed ID: 9067445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic agonist oxotremorine-M-induced long-term depression in rat cerebral cortex.
    Lin Y; Phillis JW
    Brain Res Bull; 1991 Jul; 27(1):115-7. PubMed ID: 1682019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interactions between muscarinic M2 receptors and 5-hydroxytryptamine (5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat.
    Eglen RM; Peelle B; Pulido-Rios MT; Leung E
    Br J Pharmacol; 1996 Oct; 119(3):595-601. PubMed ID: 8894184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M.
    Chintoh A; Fulton J; Koziel N; Aziz M; Sud M; Yeomans JS
    Pharmacol Biochem Behav; 2003 Aug; 76(1):53-61. PubMed ID: 13679217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons.
    Zhang HM; Li DP; Chen SR; Pan HL
    J Pharmacol Exp Ther; 2005 May; 313(2):697-704. PubMed ID: 15640398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic properties of desipramine and amoxapine: assessment using a thermoregulation paradigm.
    Dilsaver SC; Davidson R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):581-99. PubMed ID: 3423268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.